OTC Drugmaker CoLabs Int'l Withdraws IPO Filing

By Ben Glickman CoLabs Int'l, which develops technology to make over-the-counter drugs, has requested the withdrawal of its initial public offering filing....

Related Keywords

Ben Glickman ,Quantasphere Technology ,Exchange Commission ,Labs Int L ,Nasdaq Capital Market ,Article Normal ,Pharmaceuticals ,Healthcare Life Sciences ,Corporate Changes ,Stock Listings ,Corporate Funding ,Share Capital ,Initial Public Offerings ,Corporate Actions ,Corporate Industrial News ,Content Types ,Factiva Filters ,C Amp Ampe Industry News Filter ,Synd ,Corporate ,Industrial News ,Healthcare ,Life Sciences ,